Empowering dialysis users and caregivers
Search for dialysis centres here
Log in to explore the world's most comprehensive database of dialysis centres for free!
Professional dialysis recruitment| Cediranib Demonstrates Safe, Well Tolerated Antitumour Activity in Patients ... - DG News |
 |
 |
|
DG News[Presentation title: Cediranib (Recentin) in Patients With Advanced Renal Cell Carcinoma (RCC): Final Results of a Phase II Randomised Study. ...Antiangiogenesis Agent Pazopanib Well Tolerated, Offers Clinical Benefits in ... read more |
